Current and future state of clinical pharmacist-led precision medicine initiatives

Abstract

This white paper evaluates the current and future state of clinical pharmacist-led precision medicine initiatives, focusing on an overview of pharmacogenomics (PGx) in three key areas: clinical practice, education, and research. These key facets are described in detail, followed by a review of potential and perceived barriers concerning PGx and recommendations for the clinical pharmacist's role in overcoming these barriers. This paper reviews the current state of clinical pharmacist-led precision medicine and presents a vision for the future of pharmacy practice in this quickly evolving field.